Current shreds of evidence on the anticancer role of EGCG in triple negative breast cancer: an update of the current state of knowledge

Triple-Negative Breast Cancer (TNBC), represents a subtype of breast cancer in which the estrogens receptor (ER) negative, the progesterone receptor (PR) negative and the human epidermal growth factor receptor 2 (HER2) negative, are not expressed. Thusly, TNBC does not respond to hormonal therapies...

Descripción completa

Detalles Bibliográficos
Autores principales: Bimonte, Sabrina, Cascella, Marco, Barbieri, Antonio, Arra, Claudio, Cuomo, Arturo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954554/
https://www.ncbi.nlm.nih.gov/pubmed/31938038
http://dx.doi.org/10.1186/s13027-020-0270-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954554/
https://www.ncbi.nlm.nih.gov/pubmed/31938038
http://dx.doi.org/10.1186/s13027-020-0270-5

Ejemplares similares